Astec LifeSciences Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on July 28, 2025 at 4. 00 p.m.
ASTEC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Astec LifeSciences has submitted its Annual Report for FY2024-25 and announced its 31st AGM to be held on July 28, 2025 at 4:00 PM via video conferencing. The Register of Members and Share Transfer Books will be closed from July 23 to July 27, 2025, with the e-voting cut-off date set as July 21, 2025. The annual report reveals a sharp deterioration in financials: total income fell to Rs 386.93 crore from Rs 463.82 crore, and the company reported a loss after tax of Rs 134.71 crore versus Rs 46.89 crore loss in the previous year. Export sales dropped 21.1% year-on-year and CDMO share declined to 46% from 60%, with gross margin compressing to 22.1% from 30.3%.
This is a procedural AGM filing with a deeply negative financial performance embedded in the annual report. Shareholders should brace for a likely disappointing shareholder experience given widened losses, rising debt-equity ratio (2.36 vs 1.34), and continued destocking headwinds, though management remains optimistic on a CDMO-driven medium-term recovery.